PEP-Therapy
Innovative peptides
as targeted therapies for oncology
LATEST NEWS
September 26th, 2024
We are pleased to announce the publication of our translational study in BBA – Molecular Basis of Disease, showing that our lead product, PEP-010, induces apoptosis in cancer cells, which can be monitored by pharmacodynamic biomarkers.
+ READ MORE
September 3rd, 2024
We are thrilled to announce the publication of our work in Frontiers in Pharmacology, showing that our lead product, PEP-010, is effective in monotherapy and in combination with paclitaxel in resistant ovarian adenocarcinoma.
+ READ MORE
June 4th, 2024
We are happy to share updates on our PEP-010 program at the EACR Annual Meeting which will be held June 10-13 in Rotterdam, Netherlands.
Come and visit our posters!
